SteinmanMA, LandefeldCS, GonzalesR.Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA2003;289:719–25.
2.
ResiD, MilandriM, MoroML, Antibiotic prescriptions in children. J Antimicrob Chemother2003;52:282–6.
3.
KowalskiRP, PandyaAN, KarenchakLM, An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology2001;108:1826–9.
4.
GoldsteinMH, KowalskiRP, GordanJ.Emerging fluoroquinolone resistance in bacterial keratitis: A five-year review. Ophthalmology1999;106:1313–18.
5.
HwangDG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol2004;49:S79–S83.
6.
ForceRW, HartMC, PlummerSA, Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg1995;121:880–4.
7.
OzagarA, KocA, CiprutA, Effects of topical otic preparations on hearing in chronic otitis media. Otolaryngol Head Neck Surg1997;117:405–8.
8.
SpektorZ, JasekMC, JashewayD, Pharmacokinetics of topical CiproDex otic suspension in pediatric and adolescent patients after tympanostomy tube surgery. Presented at the annual meeting of the American Society of Pediatric Otolaryngology; May 2–3, 2004; Phoenix.
9.
ItoK, ItoY, MizutaK, Bacteriology of chronic otitis media, chronic sinusitis, and paranasal mucopyocele in Japan. Clin Infect Dis1995;20(suppl 2):S214–S219.
10.
HwangJH, ChuCK, LiuTC. Changes in bacteriology of discharging ears. J Laryngol Otol2002;116:686–9.
11.
PerryDA, RolandPS, StromanDW. The microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg [accepted for publication June 7, 2005].
12.
BlondeauJM, ZhaoX, HansenG, DrlicaK.Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother2001;45:433–8.
13.
StromanDW, RolandPS, DoharJ, BurtW.Microbiology of normal external auditory canal. Laryngoscope2001;111:2054–9.
14.
RolandPS, StromanDW. Microbiology of acute otitis externa. Laryngoscope2002;112:1166–77.
15.
CarmanRJ, WoodburnMA. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora. Regul Toxicol Pharmacol2001;33:276–84.
16.
AcarJF. A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora. Chemotherapy2001;47(suppl 3):15–23.
17.
HoPL, ChowKH, MakGC, Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong. Emerg Infect Dis2004;10:1960–2.
18.
van HasseltP, van KregtenE.Treatment of chronic suppurative otitis media with ofloxacin in hydroxypropyl methylcellulose ear drops: A clinical/bacteriological study in a rural area in Malawi. Int J Pediatr Otorhinolaryngol2002;63:49–56.
19.
NeuhauserMM, WeinsteinRA, RydmanR, Antibiotic resistance among gram-negative bacilli in US intensive care units. JAMA2003;289:885–8.
20.
DavisR, MarkhamA, BalfourJA. Ciprofloxacin—An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs1996;51:1019–74.
21.
AltuntasA, AslanA, ErenN, Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin. Eur Arch Otorhinolaryngol1996;253:364–6.
22.
JangCH, ParkSY. Emergence of ciprofloxacin-resistant Pseudomonas in pediatric otitis media. Int J Pediatr Otorhinolaryngol2003;67:313–16.
23.
CouzosS, LeaT, MuellerR, Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: A community-based, multicentre, double-blind randomised controlled trial. Med J Aust2003;179:185–90.
24.
SchraderN, IsaacsonG.Fungal otitis externa—Its association with fluoroquinolone eardrops [letter]. Pediatrics2003;111:1123.
25.
IsaacsonG.Treatment of otitis externa [letter]. Pediatr Infect Dis J2003;22:759.
26.
VennewaldI, SchonlebeJ, KlemmE.Mycological and histological investigations in humans with middle ear infections. Mycoses2003;46:12–18.
27.
SuzukiK, NishimuraT, BabaS, Topical ofloxacin for chronic suppurative otitis media and acute exacerbation of chronic otitis media: Optimum duration of treatment. Otol Neurotol2003;24:447–52.
28.
DoharJ.Microbiology of otorrhea in children with tympanostomy tubes: Implications for therapy. Int J Pediatr Otorhinolaryngol2003;67:1317–23.
29.
WeberPC, RolandPS, HannleyM, The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg2004;130(3 suppl):S89–94.
30.
ClaytonMI, OsborneJE, RutherfordD, RivronRP. A double-blind, randomized, prospective trial of a topical antiseptic versus a topical antibiotic in the treatment of otorrhoea. Clin Otolaryngol Allied Sci1990;15:7–10.
31.
MiroN.Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension. Otolaryngol Head Neck Surg2000;123:617–23.
32.
SuzukiK, BabaS.Antimicrobial ear drop medication therapy. Acta Otolaryngol Suppl1996;525:68–72.
33.
AslanA, AltuntasA, TitizA, A new dosage regimen for topical application of ciprofloxacin in the management of chronic suppurative otitis media. Otolaryngol Head Neck Surg1998;118:883–5.
34.
TutkunA, OzagarA, KocA, Treatment of chronic ear disease. Topical ciprofloxacin vs topical gentamicin. Arch Otolaryngol Head Neck Surg1995;121:1414–16.